Lakefront Biotherapeutics NV (AMS:LKFT)
Netherlands · Delayed Price · Currency is EUR 25.80
+0.52 (2.06%)
At close: Jun 26, 2026
Lakefront Biotherapeutics NV Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw a major transformation, highlighted by the Ouro Medicines deal and rebranding to Lakefront Biotherapeutics. Financials improved with a net profit of EUR 14.5 million and strong cash reserves, while guidance reflects robust funding for future growth.